Please read and agree to the terms and conditions of this site.
@tech.eu 1 year ago
EU-backed healthcare project rolls out platform for federated learning in drug discovery
@techcrunch.com 2 years ago
Flagship Pioneering’s new venture is betting on tRNA to treat “thousands of diseases”
@xconomy.com 3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com 3 years ago
Bristol Myers’s Hirawat on Pipeline Progress, Clinical Trial Diversity
@xconomy.com 4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@techcrunch.com 4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@xconomy.com 4 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com 5 years ago
GenCure Plans Adult Stem Cell Lab at San Antonio “Innovation Center”
@xconomy.com 5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com 5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com 5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@techcrunch.com 5 years ago
China is funding the future of American biotech
@xconomy.com 5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@techcrunch.com 5 years ago
HP is ‘printing’ drugs for the CDC to speed up antibiotic testing
@Primary_Immune 6 years ago
To All Who Worked in the Past Year to Bring Medical Treatments and Cures...Thank You! #OpenScience #science #ChildhoodCancer #RareDisease #cancer #genetics #genomics #CRISPR #GeneTherapy #GlobalHealth #ITRTG #StemCell #biotech #pharma #BigData #SNRTG #research https://t.co/4WKLJdUWbE